Alpha DNA Investment Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-24,950
| Closed | -$390K | – | 237 |
|
|
2024
Q3 | $390K | Buy |
24,950
+4,597
| +23% | +$71.9K | 0.15% | 182 |
|
|
2024
Q2 | $349K | Buy |
+20,353
| New | +$349K | 0.14% | 180 |
|
|
2021
Q2 | – | Sell |
-28
| Closed | -$3K | – | 458 |
|
|
2021
Q1 | $3K | Sell |
28
-6
| -18% | -$643 | ﹤0.01% | 493 |
|
|
2020
Q4 | $5K | Buy |
+34
| New | +$5K | 0.01% | 370 |
|